The Boceprevir and Sildenafil Pharmacokinetics Study
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
This is a healthy volunteer study looking at the interactions between two drugs: boceprevir
and sildenafil.
New drugs are being developed to treat people with the chronic viral infection hepatitis C.
Very little is know how these new treatments interact with other medications such as the
drugs used to treat erectile dysfunction.
The purpose of this study is to look at levels of both a new hepatitis C drug called
boceprevir (BOC) and an existing erectile dysfunction drug called sildenafil to see if they
affect the blood levels of each other when given separately and together.